• Fierce Pharma
  • Fierce Biotech
  • Fierce Healthcare
  • Fierce Life Sciences Events
  • Advertise
  • About Us
Home
  • Pharma
    • Vaccines
    • Asia
    • Cell & Gene Therapy
    • Drug Delivery
    • Executives
  • Manufacturing
    • Facilities
    • Recalls
    • Warning Letters
  • Marketing
  • Special Reports
  • Fierce 50
    • Special Report
    • Awards Gala
  • Trending
    • Oncology
    • Supply Chain
  • Awards
    • CRO Awards
    • Innovation Awards
    • Pharma Marketing Awards
  • Resources
    • Podcasts
    • Fierce Events
    • Industry Events
    • Webinars
    • Whitepapers
    • Survey
  • Events
  • Subscribe
Home
Subscribe
Hamburger Menu Hamburger Menu
  • Pharma
    • Vaccines
    • Asia
    • Cell & Gene Therapy
    • Drug Delivery
    • Executives
  • Manufacturing
    • Facilities
    • Recalls
    • Warning Letters
  • Marketing
  • Special Reports
  • Fierce 50
    • Special Report
    • Awards Gala
  • Trending
    • Oncology
    • Supply Chain
  • Awards
    • CRO Awards
    • Innovation Awards
    • Pharma Marketing Awards
  • Resources
    • Podcasts
    • Fierce Events
    • Industry Events
    • Webinars
    • Whitepapers
    • Survey
  • Events
  • Subscribe
  • Fierce Pharma
  • Fierce Biotech
  • Fierce Healthcare
  • Fierce Life Sciences Events
  • Advertise
  • About Us

priority review

speedometer accelerate fast speed push
Favicon Fierce Biotech

FDA opens national priority fast track, offering 2-month reviews

The FDA has begun accepting applications for a fast-track pilot, giving medicines that align with U.S. priorities an accelerated route to market.
Nick Paul Taylor Jul 23, 2025 6:35am
Narasimhan

Novartis complies with FDA 'flexibility' ask in Pluvicto filing

Oct 29, 2024 10:51am
dupixent

FDA speeds Sanofi, Regeneron's application for Dupixent in COPD

Feb 22, 2024 11:25pm
Redbrick building with Sarepta name and logo

Sarepta's Elevidys expansion bid gets fast review without adcomm

Feb 16, 2024 11:05am
dengue fever

Takeda's dengue vaccine gets moved up in the FDA review queue

Nov 23, 2022 10:30am
FDA

Seagen's Tukysa picks up FDA priority review in Herceptin combo

Sep 20, 2022 10:59am

Home
  • Connect
    • The Team
    • Advertise
    • Marketing Kit
    • Let's Talk
  • Join Us
    • Newsletters
    • Resources
    • RSS Feeds
  • Our Brands
    • Fierce Biotech
    • Fierce Healthcare
    • Fierce Pharma
  • Our Events
    • Life Sciences Events
©2025 Questex LLC All rights reserved.
Terms of use
Privacy Policy
Privacy Settings